NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/24/2025
Back to search
Official data from USPTO
CYTOSHOOTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CYTOSHOOTER
ST13
US500000098610235Class
5, 40, 42
Filing
98610235
Registration
7840326
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/24/2025
Trademark type
Word
Nice classes
5, 40, 42
Filing date
06/20/2024
Registration date
06/24/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/24/2025
Last transaction
06/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
SOLANO, CARLITA JAYE
Law office
O10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
Representatives
Bassam N. Ibrahim Buchanan Ingersoll & Rooney PC
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of infectious or parasitic diseasesneoplasmsdiseases of the blood or blood-forming organsdiseases of the immune systemendocrine nutritional or metabolic diseasesmental behavioral or neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the visual systemdiseases of the ear or mastoid processdiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skindiseases of the musculoskeletal system or connective tissuediseases of the genitourinary systemconditions related to sexual healthpregnancychildbirth or the puerperiumcertain conditions originating in the perinatal perioddevelopmental anomalies; Synthetic peptides for medical use for the treatment of infectious or parasitic diseasesneoplasmsdiseases of the blood or blood-forming organsdiseases of the immune systemendocrine nutritional or metabolic diseasesmental behavioral or neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the visual systemdiseases of the ear or mastoid processdiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skindiseases of the musculoskeletal system or connective tissuediseases of the genitourinary systemconditions related to sexual healthpregnancychildbirth or the puerperiumcertain conditions originating in the perinatal perioddevelopmental anomalies; Chemical preparations for sanitary use for medical use
Class 40
Contract biomanufacturing service in the field of pharmaceuticals for others; Contract biomanufacturing service in the field of pharmaceutical compound synthesis for others; Contract biomanufacturing service in the field of peptide synthesis for others
Class 42
Testinginspection or research of pharmaceuticalscosmetics or foodstuffs; Conducting clinical trials for others; Research and development in the field of biotechnology; Pharmaceutical research into new drugs and development of drugs for others; Pharmaceutical and biological product development consultation relating to peptide; Pharmaceutical and biological product development for others relating to peptide
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/06/2025
PUBO
PUBLISHED FOR OPPOSITION
05/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/30/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/23/2025
GNRT
NON-FINAL ACTION E-MAILED
01/23/2025
CNRT
NON-FINAL ACTION WRITTEN
01/23/2025
DOCK
ASSIGNED TO EXAMINER
01/14/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2025
NWAP
NEW APPLICATION ENTERED
06/20/2024
Continuous trademark protection
Get notified about every new filing that threatens CYTOSHOOTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.